Gestational trophoblastic tumours following initial diagnosis of partial hydatidiform mole

Autor: K. D. BAGSHAWE, S. D. LAWLER, F. J. PARADINAS, J. DENT, P. BROWN, G. M. BOXER
Rok vydání: 1990
Předmět:
Adult
medicine.medical_specialty
Time Factors
medicine.medical_treatment
Trophoblastic Neoplasms
Chorionic Gonadotropin
Gestational trophoblastic tumour
Diagnosis
Differential

Chorioepithelioma
Molar pregnancy
Pregnancy
Risk Factors
medicine
Humans
Registries
reproductive and urinary physiology
Partial Hydatidiform Mole
Retrospective Studies
Gynecology
Chemotherapy
Retrospective review
Ploidies
business.industry
Obstetrics
Hydatidiform Mole
Invasive

Choriocarcinoma
Obstetrics and Gynecology
Retrospective cohort study
General Medicine
DNA
Neoplasm

Hydatidiform Mole
Middle Aged
medicine.disease
Flow Cytometry
female genital diseases and pregnancy complications
embryonic structures
Uterine Neoplasms
Gestation
Female
Pregnancy
Multiple

business
Pregnancy Complications
Neoplastic

Follow-Up Studies
Zdroj: Lancet (London, England). 335(8697)
ISSN: 0140-6736
Popis: 11 patients registered with an initial diagnosis of partial hydatidiform mole (PHM) subsequently required chemotherapy for a gestational trophoblastic tumour. In a retrospective review by histopathological examination and measurement of DNA ploidy, the diagnosis was confirmed as PHM in 5 cases and revised to complete hydatidiform mole in 4; in 2 cases there was no evidence of a molar pregnancy. 4 of the patients with PHM had no other known pregnancy before the gestational trophoblastic tumour and in 2 of these patients the tumour was diagnosed histologically as choriocarcinoma. Not all patients in whom PHM was diagnosed at referring hospitals proved to have the condition. Although the risk of a patient with PHM requiring chemotherapy for gestational trophoblastic tumour is of the order of 1 in 200, compared with 1 in 12 after a complete mole, there is no justification for excluding a patient from follow-up after the evacuation of a PHM.
Databáze: OpenAIRE